Vaccines need to be rationally designed in order be delivered to the immune system for maximizing induction of dynamic immune responses. Virus-like particles (VLPs) are ideal platforms for such 3D vaccines, as they allow the display of complex and native antigens in a highly repetitive form on their surface and can easily reach lymphoid organs in intact form for optimal activation of B and T cells. Adjusting size and zeta potential may allow investigators to further fine-tune delivery to lymphoid organs. An additional way to alter vaccine transfer to lymph nodes and spleen may be the formulation with micron-sized adjuvants that creates a local depot and results in a slow release of antigen and adjuvant. Ideally, the adjuvant in addition sti...
Many viral structural proteins are capable of spontaneously self-assembling into structures that res...
There have been significant developments in the design of nanostructured scaffolds for eliciting rob...
The development of virus-like particle (VLP) based vaccines for human papillomavirus, hepatitis B an...
Virus-like particles (VLPs) have become key tools in biology, medicine and even engineering. After t...
This review presents data on commercial and experimental virus-like particle (VLP) vaccines, includi...
Virus-like particles (VLPs) have made giant strides in the field of vaccinology over the last three ...
Virus-like particles (VLPs) are a versatile, safe, and highly immunogenic vaccine platform. Recently...
Vaccination is deemed as the most successful intervention in public health1. As the overall life spa...
The structure, uniformity, stability, and functions of virus-like particles (VLPs) have encouraged s...
Virus-like particles (VLPs) are icosahedral protein nanoparticles with inherent immunogenicity quali...
This review presents data on commercial and experimental virus-like particle (VLP) vaccines, includi...
Virus-like particles (VLPs) are a class of subunit vaccines that differentiate themselves from solub...
Vaccines containing whole viruses induce strong, protective humoral and cellular immune responses, w...
Subunit viral vaccines are typically not as efficient as live attenuated or inactivated vaccines at ...
Vaccination is one of the most powerful examples of scientific endeavour resulting in clear benefits...
Many viral structural proteins are capable of spontaneously self-assembling into structures that res...
There have been significant developments in the design of nanostructured scaffolds for eliciting rob...
The development of virus-like particle (VLP) based vaccines for human papillomavirus, hepatitis B an...
Virus-like particles (VLPs) have become key tools in biology, medicine and even engineering. After t...
This review presents data on commercial and experimental virus-like particle (VLP) vaccines, includi...
Virus-like particles (VLPs) have made giant strides in the field of vaccinology over the last three ...
Virus-like particles (VLPs) are a versatile, safe, and highly immunogenic vaccine platform. Recently...
Vaccination is deemed as the most successful intervention in public health1. As the overall life spa...
The structure, uniformity, stability, and functions of virus-like particles (VLPs) have encouraged s...
Virus-like particles (VLPs) are icosahedral protein nanoparticles with inherent immunogenicity quali...
This review presents data on commercial and experimental virus-like particle (VLP) vaccines, includi...
Virus-like particles (VLPs) are a class of subunit vaccines that differentiate themselves from solub...
Vaccines containing whole viruses induce strong, protective humoral and cellular immune responses, w...
Subunit viral vaccines are typically not as efficient as live attenuated or inactivated vaccines at ...
Vaccination is one of the most powerful examples of scientific endeavour resulting in clear benefits...
Many viral structural proteins are capable of spontaneously self-assembling into structures that res...
There have been significant developments in the design of nanostructured scaffolds for eliciting rob...
The development of virus-like particle (VLP) based vaccines for human papillomavirus, hepatitis B an...